Showing results (161-170 of 636) with videos related to
Sort By:
Pageof 64
BJU International|June 15, 1999
Endocrine effects, efficacy and tolerability of a 10.8-mg depot formulation of goserelin acetate administered every 13 weeks to patients with advanced prostate cancerM F Sarosdy, P F Schellhammer, M S Soloway, et al.Prostate Cancer and Prostatic Diseases|December 24, 2002
Proteinchip(R) surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixturesG L Wright, L H Cazares, S-M Leung, et al.The Prostate|January 19, 2000
Identification of a superimmunoglobulin gene family member overexpressed in benign prostatic hyperplasiaG L Wright, M L Beckett, K R Newhall, et al.Cancer Research|January 1, 1986
Human prostate tissue antigens defined by murine monoclonal antibodiesJ J Starling, S M Sieg, M L Beckett, et al.International Journal of Oncology|September 21, 2000
Overexpression of p53 in prostate carcinoma is associated with improved overall survival but not predictive of response to radiotherapyL S Incognito, L H Cazares, P F Schellhammer, et al.Urology|December 1, 1996
Free and complexed prostate-specific antigen serum ratios to predict probability of primary prostate cancer and benign prostatic hyperplasiaG M Marley, M C Miller, M W Kattan, et al.F1000Research|January 13, 2015
BiSpectral Index (BIS) monitoring may detect critical hypotension before automated non-invasive blood pressure (NIBP) measurement during general anaesthesia; a case reportMatthew M J SmithThe Journal of Urology|August 1, 1995
Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancerM F Sarosdy, R W deVere White, M S Soloway, et al.Reproduction (Cambridge, England)|June 27, 2001
Neural signals that regulate GnRH neurones directly during the oestrous cycleM J Smith, L JennesPageof 64